Azenta, Inc. - SIC # 8748 - BUSINESS CONSULTING SERVICES, NOT ELSEWHERE CLASSIFIED

Ticker Exchange SIC # Website Latest Ticker
AZTA Nasdaq 8748 www.azenta.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Azenta, Inc.

Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks - May 21st, 2026 5:48 pm
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report - May 21st, 2026 2:05 pm
1 Russell 2000 Stock Worth Your Attention and 2 We Question - May 16th, 2026 11:40 pm
Azenta’s Q1 Earnings Call: Our Top 5 Analyst Questions - May 16th, 2026 5:16 pm
Azenta, Inc. Q2 2026 Earnings Call Summary - May 6th, 2026 2:48 pm
Azenta Q2 Earnings Call Highlights - May 6th, 2026 8:55 am
Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029 - May 5th, 2026 2:30 pm
How The Azenta (AZTA) Investment Narrative Is Shifting As Analysts Recut Valuation Targets - May 3rd, 2026 12:07 pm
Assessing Azenta (AZTA) Valuation After Recent Share Price Volatility - May 2nd, 2026 7:19 pm
Evercore Cuts Azenta (AZTA) Price Target, Keeps Outperform Rating - Apr 30th, 2026 3:52 pm
Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast - Apr 29th, 2026 2:05 pm
Azenta (AZTA) Fell on Operational Challenges and Uneven Execution - Apr 28th, 2026 7:28 am
2 Cash-Heavy Stocks on Our Buy List and 1 We Turn Down - Apr 23rd, 2026 7:49 pm
1 Healthcare Stock to Target This Week and 2 We Ignore - Apr 22nd, 2026 5:41 pm
3 Stocks Under $50 We’re Skeptical Of - Apr 17th, 2026 1:12 pm
Assessing Azenta (AZTA) Valuation After A Short-Term Rebound And Longer-Term Share Price Weakness - Apr 7th, 2026 3:13 pm
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution - Apr 7th, 2026 6:15 am
Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know - Mar 27th, 2026 12:17 pm
Q4 Earnings Highs And Lows: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks - Mar 23rd, 2026 6:14 pm
1 Cash-Producing Stock with Exciting Potential and 2 We Ignore - Mar 20th, 2026 10:57 am